Saturday 17 October 2026 Export NKTR’s income statement to Excel — free account

Nektar Therapeutics

Nektar Therapeutics' revenue for fiscal 2025 (year ended December 2025) was $55.2 million, down 43.9% from fiscal 2024. In the quarter to June 2026, revenue fell 9.34%, EPS grew 58.3% and free cash flow fell 65.7%, each against the same quarter a year earlier.

35.78 1.94 −5.14%

Follow NKTR

Alert me

Market cap: $1.3B
P/E: 0.0×
Fwd P/E: −6.3×
Dividend yield: —
F-score: 3/9
Altman Z: −17.07
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		17.22	12.91	31.99	42.27
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(22.11)	(10.98)	(40.18)	(30.45)
P/B ratio Full definition →		12.67	7.94	3.09	2.56
Price to Tangible BV Full definition →		13.49	8.42	3.12	2.57
EV/Sales Full definition →		20.93	17.56	30.80	38.94
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(6.91)	(4.65)	(8.41)	(9.09)
EV/FCF Full definition →		(6.88)	(4.65)	(8.40)	(9.08)
Quick Ratio Full definition →		4.07	4.59	9.85	9.64
Current Ratio Full definition →		4.24	4.97	10.21	10.42
Net Debt/EBITDA Full definition →		8.21	10.30	14.02	14.96
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.21	0.19	0.11	0.08
Operating CF/Net income Full definition →		1.37	1.80	0.99	1.87
Capex/Depreciation Full definition →		0.09	0.00	0.01	0.03
Interest Coverage Full definition →		(5.24)	(2.83)	(4.92)	(5.88)
Research and Development Expense of Revenue Full definition →		231.15%	136.25%	328.51%	386.23%
Selling, General and Administrative Expense of Revenue Full definition →		136.30%	51.29%	123.74%	126.00%
Intangible Assets out of Total Assets Full definition →		0.02	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		26.06%	10.06%	30.89%	33.21%
Graham Net Nets Full definition →		0.06	0.11	0.23	0.24
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(14.00%)	(24.12%)	(11.70%)	(9.60%)
Free Cash Flow Yield Full definition →		(17.66%)	(29.26%)	(11.46%)	(10.14%)
Revenue per Share Full definition →		0.62	1.29	0.44	0.31
Operating CF per Share Full definition →		(2.57)	(3.85)	(1.79)	(2.29)
Capex per Share Full definition →		(0.01)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(2.58)	(3.85)	(1.79)	(2.30)
Cash per Share Full definition →		14.26	14.57	22.99	20.70
Shareholders Equity per Share Full definition →		4.49	5.32	23.29	27.32
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.49	5.32	23.29	27.32
Free Cash Flow Full definition →		(48.87)	(64.98)	(44.32)	(75.86)
Working Capital Full definition →		215.02	212.73	531.33	668.42
Capital Expenditures Full definition →		(0.11)	(0.02)	(0.02)	(0.09)
Net Current Asset Value Full definition →		65.10	75.69	401.99	547.39
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.01	0.00	0.00	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →		12.07	11.17	13.93	19.59
Average Assets Full definition →		304.66	292.13	509.76	651.33
Average Common Equity Full definition →		66.99	75.28	294.98	439.46

Show all line items

Columns are period end dates

Stockrow Weekly